Oral treatment of the TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  The Prostate

• Publication date

  2005-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pros.20260PMID 15789364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.

  2005influential reference
• Oral treatment of TRAMP mice with doxazosin suppresses prostate cancer metastasis

  2004influential reference
• American Association for Cancer Research

  2004cited by this paper
• Apoptotic impact of α1‐blockers on prostate cancer growth: A myth or an inviting reality?

  2004cited by this paper
• Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.

  2004cited by this paper
• Induction of anoikis by doxazosin in prostate cancer cells is associated with activation of caspase-3 and a reduction of focal adhesion kinase

  2004cited by this paper
• Reciprocal regulation of MelCAM and AKT in human melanoma

  2003cited by this paper
• Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model

  2003cited by this paper
• Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.

  2003influential reference
• Induction of prostate apoptosis by α1-adrenoceptor antagonists: mechanistic significance of the quinazoline component

  2002cited by this paper
• A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.

  2001cited by this paper
• Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues

  2001cited by this paper
• Apoptotic activity of doxazosin on prostate stroma in vitro is mediated through an autocrine expression of TGF-beta1.

  2001cited by this paper
• Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic ability.

  2001cited by this paper
• Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.

  2001cited by this paper
• Apoptotic activity of doxazosin on prostate stroma in vitro is mediated through an autocrine expression of TGF‐β1

  2001cited by this paper
• Doxazosin: a new cytotoxic agent for prostate cancer?

  2000cited by this paper
• Medical Therapy for Benign Prostatic Hyperplasia: A Review of the Literature

  2000cited by this paper
• Double–Blind Trial of the Efficacy and Tolerability of Doxazosin in the Gastrointestinal Therapeutic System, Doxazosin Standard, and Placebo in Patients with Benign Prostatic Hyperplasia

  2000cited by this paper
• Prostate innervation.

  1998cited by this paper
• A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.

  1998cited by this paper
• The pathogenesis of benign prostatic hyperplasia: a proposed hypothesis and critical evaluation.

  1998cited by this paper
• Stem cell features of benign and malignant prostate epithelial cells.

  1998cited by this paper
• Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia.

  1998influential reference
• Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model

  1996cited by this paper
• Prostate cancer in a transgenic mouse.

  1995influential reference
• Identification of bone marrow micrometastases in patients with prostate cancer

  1994cited by this paper
• Identification, quantification, and localization of mRNA for three distinct alpha 1 adrenergic receptor subtypes in human prostate.

  1993cited by this paper
• Molecular and cellular markers for metastatic prostate cancer

  1993cited by this paper
• Neuroendocrine differentiation in human prostatic carcinoma.

  1992cited by this paper
• Neuroendocrine differentiation in human prostatic carcinoma

  1992cited by this paper
• Reciprocal mesenchymal-epithelial interaction affecting prostate tumour growth and hormonal responsiveness.

  1991cited by this paper
• Regulation of differentiation and growth of normal adult and neoplastic epithelia by inductive mesenchyme.

  1991cited by this paper
• Toward the primary prevention of cancer.

  1991cited by this paper
• Fibroblast-Mediated Human Epithelial Tumor Growth and Hormonal Responsiveness in Vivo

  1991cited by this paper
• Clinical evidence for and implications of the multistep development of prostate cancer.

  1990cited by this paper
• Role of alpha‐adrenergic blockers in the treatment of benign prostatic hyperplasia

  1990cited by this paper
• Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium

  year unknowncited by this paper

• Harnessing prazosin for tumors: Liposome hybrid nanovesicles activate tumor immunotherapy via autophagy inhibition.

  2025cites this paper
• Chapter 13 Dual Role of METCAM / MUC 18 Expression in the Progression of Cancer Cells

  2019cites this paper
• Prazosin induced lysosomal tubulation interferes with cytokinesis and the endocytic sorting of the tumour antigen CD98hc.

  2018cites this paper
• Dual Role of METCAM/MUC18 Expression in the Progression of Cancer Cells

  2018cites this paper
• QUINAZOLINE + BASED ! ALPHA 1 + ADRENOCEPTOR ! ANTAGONISTS ! AND ! PROSTATE ! CANCER !

  2016cites this paper
• Tumour-induced neoneurogenesis and perineural tumour growth: a mathematical approach

  2015influential citation
• Human METCAM / MUC 18 as a Novel Biomarker to Drive and its Specific SiRNAs to Block the Malignant Progression of Prostate Cancer

  2015cites this paper
• Possible anticancer activity of rosuvastatine, doxazosin, repaglinide and oxcarbazepin.

  2014cites this paper
• Frequent and increased expression of human METCAM/MUC18 in cancer tissues and metastatic lesions is associated with the clinical progression of human ovarian carcinoma.

  2014cites this paper
• Significance of expression of human METCAM/MUC18 in nasopharyngeal carcinomas and metastatic lesions.

  2014cites this paper
• Dual Roles of METCAM in the Progression of Different Cancers

  2012cites this paper
• Fibrosis-related gene expression in the prostate is modulated by doxazosin treatment.

  2012influential citation
• Effect of doxazocin on experimentally induced prostatic hyperplasia in adult male albino rats: a histological and immunohistochemical study

  2011cites this paper
• Tea polyphenols as prostate cancer preventive agents

  2011cites this paper
• Enforced expression of METCAM/MUC18 increases tumorigenesis of human prostate cancer LNCaP cells in nude mice.

  2011cites this paper
• Doxazosin treatment alters stromal cell behavior and increases elastic system fibers deposition in rat prostate

  2010cites this paper
• Caveolae Contribute to the Apoptosis Resistance Induced by the α1A-Adrenoceptor in Androgen-Independent Prostate Cancer Cells

  2009cites this paper
• Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146.

  2009cites this paper
• Characterization of preclinical models of prostate cancer using PET-based molecular imaging

  2009cites this paper
• The Prostate 69 : 610 ^ 623 ( 2009 ) Piperazine-Designed a 1 A / a 1 D-AdrenoceptorBlocker KMUP-1 andDoxazosin ProvideDown-Regulationof AndrogenReceptor andPSAin Prostatic LNCaPCells Growthand Specifically inXenografts

  2009cites this paper
• Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists.

  2008cites this paper
• Doxazosin reduces cell proliferation and increases collagen fibers in rat prostatic lobes

  2008cites this paper
• CD146 protein in prostate cancer: revisited with two different antibodies

  2008cites this paper
• A review of phase III clinical trials of prostate cancer chemoprevention.

  2007cites this paper
• Recent progress in the discovery of Akt inhibitors as anticancer agents

  2007cites this paper
• Effect of α1-Adrenoceptor Antagonist Exposure on Prostate Cancer Incidence: An Observational Cohort Study

  2007cites this paper
• Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.

  2007cites this paper
• Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle.

  2007cites this paper
• Ability of α-TEA, alone or in combination with selenium, to induce human prostate cancer cells to undergo apoptosis via enhancement of pro-apoptotic Fas signaling and suppression of pro-life Akt signaling pathways

  2006cites this paper
• The effect of 3‐(5‐nitro‐2‐thienyl)‐9‐chloro‐5‐morpholin‐4‐yl[1,2,4]triazolo[4,3‐c]quinazoline on cell growth, cell cycle, induction of DNA fragmentation, and activity of caspase 3 in murine leukemia L1210 cells and fibroblast NIH‐3T3 cells

  2006cites this paper